Author

B. W. McColl

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:human· 1 Assay:metagenomics· 1 Organism:mouse· 1

Frequent Co-Authors

C. J. Smith· 2 shared L. McCulloch· 2 shared S. M. Allan· 2 shared A. J. Harris· 1 shared A. Malbon· 1 shared J. R. Grainger· 1 shared M. J. D. Daniels· 1 shared M. Younas· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

C. J. Smith

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Treatment with IgM-enriched intravenous immunoglobulins (IgM-IVIg) enhances clearance of stroke-associated bacterial lung infection

L. McCulloch, A. J. Harris, A. Malbon, M. J. D. Daniels, M. Younas, J. R. Grainger, S. M. Allan, C. J. Smith, B. W. McColl

This study shows that IgM-enriched intravenous immunoglobulin (IgM-IVIg) improves bacterial clearance and reduces lung inflammation after stroke.

bioRxiv · Dec 16, 2021Immunology

Interleukin-1 receptor antagonist treatment in acute ischaemic stroke does not alter systemic markers of anti-microbial defence

L. McCulloch, S. M. Allan, C. J. Smith, B. W. McColl

This study examines whether IL-1Ra treatment in acute ischaemic stroke affects systemic anti-microbial defenses, finding no significant differences in immunoglobulin and complement levels between treated and placebo groups.

bioRxiv · Mar 26, 2019Immunology